Products
FDA grants ANDA approval to olopatadine hydrochloride for ocular allergy relief
Generic of Alcon’s Pataday Once Daily Relief is intended for use as an antihistamine to treat itchy eyes.
Products
FDA grants ANDA approval for brimonidine tartrate and timolol maleate 0.2%|0.5%
Generic of AbbVie’s Combigan is formulated to lower IOP in glaucoma and ocular hypertension (OHT) patients.
Products
FDA approves ANDA for generic ketorolac tromethamine ophthalmic solution 0.5%
Generic of Allergan’s ACULAR is indicated to treat post-op pain and inflammation plus allergic conjunctivitis.
Products
FDA approves ANDA for Lupin's allergic conjunctivitis eye drop
Generic equivalent to Bausch + Lomb’s Alrex offers a lower-cost alternative for patients.
Pipeline
FDA approves ANDA for Lupin's bromfenac ophthalmic solution 0.09%
Topical drug is the generic equivalent of Bausch + Lomb’s Bromday; intended to treat pain and inflammation following cataract surgery.
Products
OCuSOFT launches Retaine Ultra PF in a multi-dose bottle
Marketed as a daily, multi-dose lubricant eye drop, this new addition offers fact-acting hydration and a “moisture-rich” formulation for sensitive eyes.
Events
Eyes On Eyecare and the Intrepid Eye Society launch new video channel
Inside Intrepid offers dynamic discussions and a rare, behind-the-scenes look at how top ODs approach and manage complex topics in clinical practice.
Research
Study: Pickleball-related eye injuries on the rise
National review finds rising emergency visits, frequent ball-strike trauma, and a clear case for protective eyewear.
Products
Eyedaptic launches latest version of AI-based smart glasses for AMD
Designed for patients with retinal diseases, the EYE7 is an integrated wearable solution with real-time vision enhancements and a new visual assistant.
Products
FDA approves FDC Limited's pilocarpine HCl ophthalmic solution
ANDA approval for generic eye drop extends to three concentrations: 1%, 2%, and 4%.
Business
Ollin Biosciences debuts with next-gen ophthalmic pipeline
Biotech launches with $100 million financing and a lead program addressing wet AMD and DME via a higher potency VEGF/Ang2 bispecific antibody.
Research
Pivotal study showcases enVista Envy IOL's full range of vision
Data includes meeting all efficacy and safety outcomes, with the lens demonstrating statistical superiority in visual outcomes and a favorable dysphotopsia profile.
Products
Scope introduces OPTASE HYLO FORTE dry eye drops
Artificial tear is formulated with active glycerin for moderate-to-severe dry eye disease, offering extra moisture and a protective cushion for long-lasting relief.
Pipeline
FDA extends review period for EYLEA HD expanded labeling
Delay follows a recent site inspection; proposed expansion includes a new indication, updated dosings for current indications, and a pre-filled syringe version.
Pipeline
4DMT releases 60-week phase 2 analysis on DME gene therapy
Reported at ASRS, data supports sustained vision gains and a 78% reduction in supplemental injections for 4D-150’s highest dose as company preps for phase 3 trial.
Business
Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes
Check out the latest leadership news from the eyecare space, including two new execs at PolyActiva and a retinal disorder treatment specialist taking the helm at Wills Eye.
Business
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.
Products
Heidelberg showcases fully digital surgical visualization platform
The SeeLuma features an ergonomically-friendly design, 3D technology, and a new intraoperative OCT module, among other add-ons, for surgeons.
Products
Haag-Streit launches METIS 900 surgical control center
Newest ophthalmic microscope system features coaxial red reflex, LED illumination, ergonomically-friendly controls, and a compact design.
Pipeline